HomeAI · summaries
Storia in 4 fonti
Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO
Most recently the leader of buzzy startup Tessera Therapeutics, Severino will look to improve the fortunes of a company facing emerging competition and declining sales for its prized gene therapy Elevidys.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO
Most recently the leader of buzzy startup Tessera Therapeutics, Severino will look to improve the fortunes of a company facing emerging competition and declining sales for its…
- ·
endpoints.news
Sarepta turns to Michael Severino as CEO, looking to move past recent turmoil
Michael Severino will replace the company’s longtime leader Doug Ingram on Tuesday. Severino joins from Flagship’s gene editing biotech Tessera Therapeutics, where he had been CEO…
